You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Ritter Pharmaceuticals implements 1-for-10 reverse stock split
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
The Market Intelligence Platform
Los Angeles-based Ritter Pharmaceuticals Inc. implemented a 1-for-10 reverse split of its common stock, effective March 23.
The split will reduce Ritter's issued and outstanding common shares to 4,940,652 from 49,406,521.
Corporate Stock Transfer Inc. is acting as exchange agent for the split.